Nitzan Rosenfeld receives Translational Research Award
Congratulations to Nitzan Rosenfeld, who has won the 2013 British Association for Cancer Research Translational Research Award.
The purpose of the award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory – clinic) cancer research.
The lab are working on developing effective methods to make use of circulating tumour DNA (ctDNA), which is found in blood and other body fluids and contains much useful information about a patient’s cancer. For example, by using genomic techniques to study ctDNA researchers can learn about the evolution of a patient’s tumour and how it is developing resistance to therapy. The advantage of using ctDNA to diagnose and monitor disease is that it can be collected relatively non-invasively, through a blood test rather than a tumour biopsy, and ease of sample collection means that you can take many more samples to follow the development and changes in a tumour.
Related News
See all news-
1M to advance AI powered personalised ovarian cancer care
19th February 2026
Researchers from our Brenton Group are part of an international team awarded the Global Ovarian Cancer Research Consortium’s inaugural AI Accelerator Grant.
Find out more -
Professor Sir Steve Jackson elected as a fellow of the American Association for Cancer Research
16th February 2026
Senior Group Leader Sir Steve Jackson has been elected as a Fellow of the American Association for Cancer Research Academy in the Class of 2026.
Find out more -
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more